Bill

Bill > S1211


MA S1211

To review the quality and patient safety of dispensing certain cancer and chronic disease related drugs


summary

Introduced
01/23/2017
In Committee
05/30/2017
Crossed Over
Passed
Dead
12/31/2018

Introduced Session

190th General Court

Bill Summary

For legislation to review the quality and patient safety of dispensing certain cancer and chronic disease related drugs. Public Health.

AI Summary

This bill directs the Health Policy Commission, in consultation with the Department of Public Health and the Division of Insurance, to study and analyze health insurance payer practices that require certain categories of drugs, including those administered by injection or infusion, to be dispensed by a third-party specialty pharmacy directly to a patient or to a healthcare provider for a specific patient's use. The Commission is required to file a report of its findings, including recommended legislation, with the Senate and House Committees on Ways and Means, the Joint Committee on Health Care Financing, and the Joint Committee on Public Health by January 1, 2018.

Committee Categories

Health and Social Services

Sponsors (4)

Last Action

Accompanied a study order, see S2535 (on 05/31/2018)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...